These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 16809162

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Management of cancer-treatment-induced bone loss in postmenopausal women undergoing adjuvant breast cancer therapy: a Z-FAST update.
    Brufsky A.
    Semin Oncol; 2006 Apr; 33(2 Suppl 7):S13-7. PubMed ID: 16730272
    [Abstract] [Full Text] [Related]

  • 3. Reducing the risk of cancer treatment-associated bone loss in patients with breast cancer.
    Hadji P, Bundred N.
    Semin Oncol; 2007 Dec; 34(6 Suppl 4):S4-10. PubMed ID: 18068489
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group.
    Reid DM, Doughty J, Eastell R, Heys SD, Howell A, McCloskey EV, Powles T, Selby P, Coleman RE.
    Cancer Treat Rev; 2008 Dec; 34 Suppl 1():S3-18. PubMed ID: 18515009
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Aromatase inhibitors and bone health.
    Bundred NJ.
    Curr Opin Obstet Gynecol; 2009 Feb; 21(1):60-7. PubMed ID: 19125005
    [Abstract] [Full Text] [Related]

  • 8. Cancer treatment-induced bone loss: pathophysiology and clinical perspectives.
    Brufsky AM.
    Oncologist; 2008 Feb; 13(2):187-95. PubMed ID: 18305064
    [Abstract] [Full Text] [Related]

  • 9. Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole.
    Brufsky A, Bundred N, Coleman R, Lambert-Falls R, Mena R, Hadji P, Jin L, Schenk N, Ericson S, Perez EA, Z-FAST and ZO-FAST Study Groups.
    Oncologist; 2008 May; 13(5):503-14. PubMed ID: 18515735
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Encounter of cancer cells with bone. Cancer treatment-induced bone loss : CTIBL].
    Takahashi S.
    Clin Calcium; 2011 Mar; 21(3):447-53. PubMed ID: 21358067
    [Abstract] [Full Text] [Related]

  • 12. Prevention of osteoporosis after breast cancer.
    Reid DM.
    Maturitas; 2009 Sep 20; 64(1):4-8. PubMed ID: 19709826
    [Abstract] [Full Text] [Related]

  • 13. Clinical review: Effect of endocrine therapies on bone in breast cancer patients.
    Santen RJ.
    J Clin Endocrinol Metab; 2011 Feb 20; 96(2):308-19. PubMed ID: 21147884
    [Abstract] [Full Text] [Related]

  • 14. Emerging bone health issues in women with breast cancer in Hawai'i.
    Carney JF, Davis J.
    Hawaii Med J; 2007 Jun 20; 66(6):164-6. PubMed ID: 17621865
    [Abstract] [Full Text] [Related]

  • 15. Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group.
    Gnant MF, Mlineritsch B, Luschin-Ebengreuth G, Grampp S, Kaessmann H, Schmid M, Menzel C, Piswanger-Soelkner JC, Galid A, Mittlboeck M, Hausmaninger H, Jakesz R, Austrian Breast and Colorectal Cancer Study Group.
    J Clin Oncol; 2007 Mar 01; 25(7):820-8. PubMed ID: 17159195
    [Abstract] [Full Text] [Related]

  • 16. Zoledronic acid prevents cancer treatment-induced bone loss.
    Oncology (Williston Park); 2005 Mar 01; 19(3):390. PubMed ID: 15828553
    [No Abstract] [Full Text] [Related]

  • 17. New results from the use of bisphosphonates in cancer patients.
    Coleman R, Gnant M.
    Curr Opin Support Palliat Care; 2009 Sep 01; 3(3):213-8. PubMed ID: 19561507
    [Abstract] [Full Text] [Related]

  • 18. Incidence and management of side effects associated with aromatase inhibitors in the adjuvant treatment of breast cancer in postmenopausal women.
    Mouridsen HT.
    Curr Med Res Opin; 2006 Aug 01; 22(8):1609-21. PubMed ID: 16870085
    [Abstract] [Full Text] [Related]

  • 19. The effect of aromatase inhibitors on bone metabolism.
    Folkestad L, Bjarnason NH, Bjerregaard JK, Brixen K.
    Basic Clin Pharmacol Toxicol; 2009 Jan 01; 104(1):3-10. PubMed ID: 19152547
    [Abstract] [Full Text] [Related]

  • 20. Hormone- and chemotherapy-induced bone loss in breast cancer.
    Coleman RE.
    Oncology (Williston Park); 2004 May 01; 18(5 Suppl 3):16-20. PubMed ID: 15202583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.